{"id":"W3047518349","doi":"10.1016/j.pediatrneurol.2020.08.001","title":"A Phase 2 Study of AMO-02 (Tideglusib) in Congenital and Childhood-Onset Myotonic Dystrophy Type 1 (DM1)","year":2020,"lang":"en","type":"article","venue":"Pediatric Neurology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":89,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"Canadian Institutes of Health Research; Canada Research Chairs; AMO Pharma; Canada Foundation for Innovation","keywords":"Myotonic dystrophy; Medicine; Tolerability; Area under the curve; Placebo; Internal medicine; Adverse effect; Anesthesia; Pediatrics; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001018931,0.001402066,0.001342627,0.0003510425,0.0003472424,0.000553142,0.0007492551,0.001003495,0.003538406],"category_scores_gemma":[0.0006053555,0.0004740142,0.0006854802,0.0002840125,0.0005150788,0.0005535761,0.0003105782,0.001945591,0.0006895826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007830525,"about_ca_system_score_gemma":0.001362447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001237846,"about_ca_topic_score_gemma":0.003541613,"domain_scores_codex":[0.9997035,0.0001259057,0.00001447328,0.00006482637,0.00003257463,0.00005884557],"domain_scores_gemma":[0.999617,0.00005350313,0.00008413019,0.00003046159,0.00003749965,0.0001773182],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5562048,0.1422271,0.01338911,0.001335001,0.001513374,0.0008865611,0.0006425625,0.002890245,0.1376871,0.0004056763,0.00652077,0.1362977],"study_design_scores_gemma":[0.3151339,0.6513904,0.02122091,0.00004167331,0.000341505,0.000784333,0.00007904005,0.001501891,0.00612161,0.0001098013,0.003241339,0.00003351813],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945163,0.001073047,0.0004793344,0.0002241998,0.00005430045,0.001875231,0.0008545491,0.00006707832,0.0008559466],"genre_scores_gemma":[0.987684,0.001432768,0.002218002,0.0006602341,0.0001051642,0.003145457,0.002221461,0.0000277478,0.002505326],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003538406,"threshold_uncertainty_score":0.01183712,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0251983148847592,"score_gpt":0.2737161198047742,"score_spread":0.248517804920015,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}